Less airway inflammation and goblet cell metaplasia in an IL-33-induced asthma model of leptin-deficient obese mice

Abstract Background Obesity-associated asthma is a phenotype of severe asthma. Late-onset, non-eosinophilic and female-dominant phenotype is highly symptomatic and difficult to treat. Leptin, an adipokine, exerts an immunomodulatory effect. IL-33 associated with innate immunity induces type 2 inflam...

Full description

Bibliographic Details
Main Authors: Atsushi Kurokawa, Mitsuko Kondo, Ken Arimura, Shigeru Ashino, Etsuko Tagaya
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Respiratory Research
Subjects:
Online Access:https://doi.org/10.1186/s12931-021-01763-3
_version_ 1829532037976948736
author Atsushi Kurokawa
Mitsuko Kondo
Ken Arimura
Shigeru Ashino
Etsuko Tagaya
author_facet Atsushi Kurokawa
Mitsuko Kondo
Ken Arimura
Shigeru Ashino
Etsuko Tagaya
author_sort Atsushi Kurokawa
collection DOAJ
description Abstract Background Obesity-associated asthma is a phenotype of severe asthma. Late-onset, non-eosinophilic and female-dominant phenotype is highly symptomatic and difficult to treat. Leptin, an adipokine, exerts an immunomodulatory effect. IL-33 associated with innate immunity induces type 2 inflammation and is present in adipose tissue. The purpose of this study was to elucidate the pathogenesis of obesity-associated asthma by focusing on the interaction between leptin and IL-33. Methods In leptin-deficient obese (ob/ob) and wild-type mice, IL-33 was instilled intranasally on three consecutive days. In part of the mice, leptin was injected intraperitoneally prior to IL-33 treatment. The mice were challenged with methacholine, and airway hyperresponsiveness (AHR) was assessed by resistance (Rrs) and elastance (Ers) of the respiratory system using the forced oscillation technique. Cell differentiation, IL-5, IL-13, eotaxin, keratinocyte-derived chemokine (KC) in bronchoalveolar lavage fluid (BALF) and histology of the lung were analyzed. For the in vitro study, NCI-H292 cells were stimulated with IL-33 in the presence or absence of leptin. Mucin-5AC (MUC5AC) levels were measured using an enzyme-linked immunosorbent assay. Results Ob/ob mice showed greater Rrs and Ers than wild-type mice. IL-33 with leptin, but not IL-33 alone, enhanced Ers rather than Rrs challenged with methacholine in ob/ob mice, whereas it enhanced Rrs alone in wild-type mice. IL-33-induced eosinophil numbers, cytokine levels in BALF, eosinophilic infiltration around the bronchi, and goblet cell metaplasia were less in ob/ob mice than in wild-type mice. However, leptin pretreatment attenuated these changes in ob/ob mice. MUC5AC levels were increased by co-stimulation with IL-33 and leptin in vitro. Conclusions Ob/ob mice show innate AHR. IL-33 with leptin, but not IL-33 alone, induces airway inflammation and goblet cell metaplasia and enhances AHR involving peripheral airway closure. This is presumably accelerated by mucus in ob/ob mice. These results may explain some aspects of the pathogenesis of obesity-associated asthma.
first_indexed 2024-12-16T18:32:10Z
format Article
id doaj.art-5cb405c041984c18a9c2aa13f2bd2b2e
institution Directory Open Access Journal
issn 1465-993X
language English
last_indexed 2024-12-16T18:32:10Z
publishDate 2021-06-01
publisher BMC
record_format Article
series Respiratory Research
spelling doaj.art-5cb405c041984c18a9c2aa13f2bd2b2e2022-12-21T22:21:16ZengBMCRespiratory Research1465-993X2021-06-0122111210.1186/s12931-021-01763-3Less airway inflammation and goblet cell metaplasia in an IL-33-induced asthma model of leptin-deficient obese miceAtsushi Kurokawa0Mitsuko Kondo1Ken Arimura2Shigeru Ashino3Etsuko Tagaya4Department of Respiratory Medicine, Tokyo Women’s Medical UniversityDepartment of Respiratory Medicine, Tokyo Women’s Medical UniversityDepartment of Respiratory Medicine, Tokyo Women’s Medical UniversityDepartment of Microbiology and Immunology, Tokyo Women’s Medical UniversityDepartment of Respiratory Medicine, Tokyo Women’s Medical UniversityAbstract Background Obesity-associated asthma is a phenotype of severe asthma. Late-onset, non-eosinophilic and female-dominant phenotype is highly symptomatic and difficult to treat. Leptin, an adipokine, exerts an immunomodulatory effect. IL-33 associated with innate immunity induces type 2 inflammation and is present in adipose tissue. The purpose of this study was to elucidate the pathogenesis of obesity-associated asthma by focusing on the interaction between leptin and IL-33. Methods In leptin-deficient obese (ob/ob) and wild-type mice, IL-33 was instilled intranasally on three consecutive days. In part of the mice, leptin was injected intraperitoneally prior to IL-33 treatment. The mice were challenged with methacholine, and airway hyperresponsiveness (AHR) was assessed by resistance (Rrs) and elastance (Ers) of the respiratory system using the forced oscillation technique. Cell differentiation, IL-5, IL-13, eotaxin, keratinocyte-derived chemokine (KC) in bronchoalveolar lavage fluid (BALF) and histology of the lung were analyzed. For the in vitro study, NCI-H292 cells were stimulated with IL-33 in the presence or absence of leptin. Mucin-5AC (MUC5AC) levels were measured using an enzyme-linked immunosorbent assay. Results Ob/ob mice showed greater Rrs and Ers than wild-type mice. IL-33 with leptin, but not IL-33 alone, enhanced Ers rather than Rrs challenged with methacholine in ob/ob mice, whereas it enhanced Rrs alone in wild-type mice. IL-33-induced eosinophil numbers, cytokine levels in BALF, eosinophilic infiltration around the bronchi, and goblet cell metaplasia were less in ob/ob mice than in wild-type mice. However, leptin pretreatment attenuated these changes in ob/ob mice. MUC5AC levels were increased by co-stimulation with IL-33 and leptin in vitro. Conclusions Ob/ob mice show innate AHR. IL-33 with leptin, but not IL-33 alone, induces airway inflammation and goblet cell metaplasia and enhances AHR involving peripheral airway closure. This is presumably accelerated by mucus in ob/ob mice. These results may explain some aspects of the pathogenesis of obesity-associated asthma.https://doi.org/10.1186/s12931-021-01763-3Airway hyperresponsivenessAsthmaEosinophilsGoblet cell metaplasiaIL-33Innate immunity
spellingShingle Atsushi Kurokawa
Mitsuko Kondo
Ken Arimura
Shigeru Ashino
Etsuko Tagaya
Less airway inflammation and goblet cell metaplasia in an IL-33-induced asthma model of leptin-deficient obese mice
Respiratory Research
Airway hyperresponsiveness
Asthma
Eosinophils
Goblet cell metaplasia
IL-33
Innate immunity
title Less airway inflammation and goblet cell metaplasia in an IL-33-induced asthma model of leptin-deficient obese mice
title_full Less airway inflammation and goblet cell metaplasia in an IL-33-induced asthma model of leptin-deficient obese mice
title_fullStr Less airway inflammation and goblet cell metaplasia in an IL-33-induced asthma model of leptin-deficient obese mice
title_full_unstemmed Less airway inflammation and goblet cell metaplasia in an IL-33-induced asthma model of leptin-deficient obese mice
title_short Less airway inflammation and goblet cell metaplasia in an IL-33-induced asthma model of leptin-deficient obese mice
title_sort less airway inflammation and goblet cell metaplasia in an il 33 induced asthma model of leptin deficient obese mice
topic Airway hyperresponsiveness
Asthma
Eosinophils
Goblet cell metaplasia
IL-33
Innate immunity
url https://doi.org/10.1186/s12931-021-01763-3
work_keys_str_mv AT atsushikurokawa lessairwayinflammationandgobletcellmetaplasiainanil33inducedasthmamodelofleptindeficientobesemice
AT mitsukokondo lessairwayinflammationandgobletcellmetaplasiainanil33inducedasthmamodelofleptindeficientobesemice
AT kenarimura lessairwayinflammationandgobletcellmetaplasiainanil33inducedasthmamodelofleptindeficientobesemice
AT shigeruashino lessairwayinflammationandgobletcellmetaplasiainanil33inducedasthmamodelofleptindeficientobesemice
AT etsukotagaya lessairwayinflammationandgobletcellmetaplasiainanil33inducedasthmamodelofleptindeficientobesemice